Biotin and Mayzent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Biotin (biotin) and Mayzent (siponimod fumaric acid). Common drug interactions include lower limb fracture among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Biotin and Mayzent. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.

What is Biotin?

Biotin has active ingredients of biotin. It is often used in hair loss. eHealthMe is studying from 35,393 Biotin users. Check the latest studies of Biotin.

What is Mayzent?

Mayzent has active ingredients of siponimod fumaric acid. eHealthMe is studying from 10,269 Mayzent users. Check the latest studies of Mayzent.



On Jul, 25, 2026

76 people who take Biotin and Mayzent together, and have interactions are studied.

Biotin and Mayzent drug interactions.

What are the common drug interactions of Biotin and Mayzent, by gender? *:

female:

  1. Lower limb fracture
  2. Ocular discomfort (a generic expression when there is lack of ease in/about the eyes)
  3. Ocular hyperaemia (an abnormally large amount of blood in eye)
  4. Photophobia (extreme sensitivity to light)
  5. Vision blurred
  6. Back pain
  7. Blood albumin decreased
  8. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  9. Herpes zoster
  10. Hip fracture

male:

  1. Pain
  2. Balance disorder
  3. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  4. Dysarthria (speech disorder)
  5. Erectile dysfunction
  6. Gait spastic
  7. Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate)
  8. Insomnia (sleeplessness)
  9. Memory impairment
  10. Micturition urgency (urgency to pass the urine)

What are the common drug interactions of Biotin and Mayzent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Menstruation irregular

40-49:

  1. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  2. Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged)
  3. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  4. Blood albumin decreased
  5. Protein total decreased
  6. Blood potassium decreased
  7. White blood cell count decreased
  8. Headache (pain in head)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Oedema (fluid collection in tissue)

50-59:

  1. Fatigue (feeling of tiredness)
  2. Pain
  3. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  4. Asthenia (weakness)
  5. Balance disorder
  6. Burning sensation
  7. Dizziness
  8. Dry mouth
  9. Joint swelling
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

60+:

  1. Fatigue (feeling of tiredness)
  2. Dizziness
  3. Muscular weakness (muscle weakness)
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Poor quality sleep
  6. Secondary progressive multiple sclerosis (a stage of ms which comes after relapsing remitting ms in many cases)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Pain
  9. Nausea (feeling of having an urge to vomit)
  10. Flushing (the warm, red condition of human skin)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 56 people, 73.68%
  2. Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 16 people, 21.05%
  3. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 6.58%

* Approximation only. Some reports may have incomplete information.

Do you take Biotin and Mayzent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Biotin and Mayzent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Biotin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mayzent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Biotin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mayzent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on biotin and siponimod fumaric acid (the active ingredients of Biotin and Mayzent, respectively), and Biotin and Mayzent (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: